Introduction {#Sec1}
============

The normal ductus arteriosus arises from the left pulmonary artery and connects to the transition area between the aortic arch and descending aorta just distal to the origin of the left subclavian artery. Physiologically, ductus arteriosus closes shortly after birth to facilitate proper breathing in the infant. Rarely it narrows and occludes prematurely during fetal life. It is estimated that 8 out of 1000 preterm infants will develop a patent ductus arteriosus (PDA), a condition in which the ductus arteriosus fails to close postnatally \[[@CR1]\].

The presence of PDA is reported to contribute to the development of feeding intolerance, necrotising enterocolitis, intracranial hemorrhage, decreased glomerular filtration rate, and bronchopulmonary dysplasia (BPD) in preterm infants \[[@CR2]\]. Initial treatment of PDA is usually pharmacological and includes indomethacin. Surgical closure is considered a standard treatment for symptomatic neonates refractory to medical therapy \[[@CR3], [@CR4]\]. During the surgical procedure, the perineurium of the left recurrent laryngeal nerve may be disrupted or the nerve may be contused or injured by the clip or ligature \[[@CR5]\]. A possible adverse event of such an injury is vocal cord paralysis (VCP). Duration of vocal cord dysfunction is variable and may be transient (\< 1 year) or persistent (\> 1 year) \[[@CR6]\].

Though VCP following PDA surgical closure is well reported in the literature, the recorded incidence of this postoperative complication varies widely, ranging from \> 1 to 64% \[[@CR7], [@CR8]\]. Previous research provided inconclusive data on its incidence due to different methodology of assessment of VCP and variable laryngoscopy scoping. As such, there was a need for a study that would unify the existing data on the incidence of VCP based on the method used to close PDA, method to assess VCP, and evaluate the influence of age and ethnic origin on patient outcome. Therefore, the objective of this meta-analysis was to estimate the incidence of VCP after surgical PDA closure in different age populations (primary outcomes), as well as identify associated risk factors and morbidities for preterm infants (secondary outcomes).

Materials and Methods {#Sec2}
=====================

Search Strategy {#Sec3}
---------------

A search of the major electronic databases, including PubMed, ScienceDirect, EMBASE, BIOSIS, SCIELO, CNKI, and Web of Science, was performed in order to identify potential studies for inclusion in the meta-analysis. No date limits or language restrictions were applied. Search terms included patent ductus arteriosus and a selection of one of the following: recurrent laryngeal nerve or vocal cord paralysis or vocal cord paresis or vocal fold dysfunction. The references of the included studies were also searched in order to identify additional articles. The authors strictly adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (see Supplementary material 1).

Study Selection Criteria {#Sec4}
------------------------

Studies were included into the meta-analysis if (1) reported clear, extractable data on the incidence of the VCP after PDA closure, (2) the study clearly defined VCP as unilateral vocal cord immobility, and (3) used clip or ligation technique for PDA closure. Meta-analysis of risk factors in preterm infants additionally included the following criteria (1) study population included preterm infants that underwent surgery for PDA, (2) outcomes reported included incidence of VCP risk factors and associated comorbidities. The following exclusion criteria were employed: (1) case studies, case reports, conference abstracts, and letters to the editor, (2) studies reporting incomplete data. Two independent reviewers assessed the eligibility of the articles for the inclusion into the meta-analysis. Any discrepancies among reviewers were resolved by a consensus among the entire review team. In case of studies published in languages other than English, medical professionals fluent in English and the original language of the article translated the texts.

Data Extraction and Quality Assessment {#Sec5}
--------------------------------------

The following data were extracted from the eligible studies: year, country, type of study and technique of PDA closure (suture ligature or clipping), sample size (number of patients), incidence of VCP, length of injury---transient or permanent (transient VCP was defined as lasting less than a year, while persistent as more than a year), patients' characteristics (age, geographical origin). Patients were divided into two groups---premature newborns/low birth weight newborns and non-premature patients (any patients that did not fit into first group). Data from any study comparing different cohorts of patients (i.e., ligation vs. clip, premature vs. non-premature patients) were extracted and treated as two separate studies for the purpose of analysis. Whenever possible, outcomes comparing VCP and non-VCP groups in premature/low birth weight patients were also extracted. These included the following: birth weight, weight at the time of surgery, age (days) at the time of surgery, gestational age, incidence of bronchopulmonary dysplasia, total days of mechanical ventilation, and incidence of gastrostomy tube insertion. Critical Appraisal of the Health Research Literature tool was used to assess the quality of studies reporting the prevalence or incidence of a health problem \[[@CR9]\]. Study quality was rated on a scale from 1 (very poor) to 8 (high). In case of any discrepancies in the data of included studies, the review team attempted to contact the authors of the original study for clarification.

Statistical Analysis {#Sec6}
--------------------

Pooled incidence estimates were calculated using random effects model with MetaXL version 5.3 by EpiGear International Pty Ltd (Wilston, QLD, Australia). Subgroup analysis based on type of PDA closure and geographical distribution of the studies was performed to probe the source of heterogeneity. Confidence intervals were used to compare the incidence rates, with any overlap between two groups indicating a lack of statistical significance.

Continuous outcomes in risk factors analysis were analyzed by calculating weighted mean difference (WMD) with the 95% confidence intervals (95%CI). Dichotomous outcomes were analyzed by calculating relative risk (RR) with the 95%CI. Reported values were two-tailed, and hypothesis-testing results were considered statistically significant at *p* \< 0.05.

Heterogeneity among included studies was assessed with the *χ*^2^ test and the *I*^2^ statistic. A Cochran's Q *p* value of \< 0.10 indicated significant heterogeneity \[[@CR10]\]. The following intervals were used to analyze heterogeneity in *I*^2^ statistic: 0--40%---might not be important; 30--60%---might indicate moderate heterogeneity; 50--90%---may indicate substantial heterogeneity; and 75--100% may represent considerable heterogeneity \[[@CR10]\].

Results {#Sec7}
=======

Literature Search {#Sec8}
-----------------

The study identification flow chart is presented in Fig. [1](#Fig1){ref-type="fig"}. The initial electronic search yielded 257 potential articles. Additional two articles were identified through reference search. After eligibility analysis, 30 articles were included in this meta-analysis.

Fig. 1Study identification flowchart

Characteristics of the Eligible Studies {#Sec9}
---------------------------------------

The characteristics of included studies with quality assessment are presented in Table [1](#Tab1){ref-type="table"}. Due to the fact that three articles \[[@CR11]--[@CR13]\] compared two different cohorts of patients, each cohort was treated as a separate study, therefore 33 studies (*n* = 4887 subjects) were included into this meta-analysis. Specifically, the study by Davis et al. \[[@CR11]\] contained two groups of patients, one treated by ligation and one by clip method, and thus for the purposes of analysis was considered as two separate studies. The study by Spanos et al. \[[@CR12]\] was treated as two separate studies for the same reason. The study by Villa et al. \[[@CR13]\] analyzed two groups of patients (low birth weight and non-premature patients), thus it was also treated as two separate studies during analysis.

Table 1Characteristics of included studiesStudy IDCountryStudy designType of PDA closureMethod to assess VCPPrematureNumber of patientsIncidence of VCP (%)Study qualityBenjamin et al. \[[@CR5]\]USAProspectiveLigationSelective scoping^b^Yes5540.07Bensky et al. \[[@CR14]\]USAProspectiveClipSelective scopingYes/No1182.56Burke et al. \[[@CR15]\]USAProspectiveLigationSymptoms only^a^Yes342.96Carpes et al. \[[@CR16]\]CanadaProspectiveLigationPre-op and post-op universal scopingNo4216.76Clement et al. \[[@CR17]\]CanadaRetrospectiveLigationUniversal scoping^c^Yes2352.26Davis et al. \[[@CR11]\]USARetrospectiveLigationSelective scopingYes684.45Davis et al. \[[@CR11]\]USARetrospectiveClipSelective scopingYes380.05Ekici et al. \[[@CR18]\]TurkeyRetrospectiveLigationSymptoms onlyYes128.36Hawkins et al. \[[@CR36]\]USARetrospectiveLigationSymptoms onlyNo205.05Heuchan et al. \[[@CR19]\]EnglandRetrospectiveLigationSymptoms onlyYes1254.86Hines et al. \[[@CR20]\]USARetrospectiveClipSelective scopingYes1005.06Ibrahim et al. \[[@CR21]\]EgyptRetrospectiveLigationSymptoms onlyYes1200.85Kang et al. \[[@CR22]\]EnglandProspectiveLigationSymptoms onlyYes1022.06Laborde et al. \[[@CR23]\]FranceRetrospectiveClipSymptoms onlyNo3321.86Liem et al. \[[@CR24]\]VietnamProspectiveClipSymptoms onlyNo580.05Mandhan et al. \[[@CR25]\]New ZealandRetrospectiveLigation and clipSymptoms onlyYes1450.76Nezafati et al. \[[@CR26]\]IranRetrospectiveClipSymptoms onlyNo13001.06Nichols et al. \[[@CR27]\]USARetrospectiveLigationSelective scopingYes53212.45Niinikoski et al. \[[@CR3]\]FinlandRetrospectiveSurgicalSymptoms onlyYes1011.05Odegard et al. \[[@CR28]\]USAProspectiveClipSymptoms onlyNo601.75Pereira et al. \[[@CR29]\]USAProspectiveLigationUniversal scopingYes6111.55Pharande et al. \[[@CR30]\]AustraliaRetrospectiveLigationSelective scopingYes3531.46Roksund et al. \[[@CR8]\]NorwayProspectiveSurgicalUniversal scopingYes1163.67Rukholm et al. \[[@CR31]\]CanadaRetrospectiveLigationOnly 31/111 patients had LAR post-opYes11117.17Smith et al. \[[@CR32]\]USAProspectiveLigationUniversal scopingYes8616.36Sørensen et al. \[[@CR33]\]DenmarkRetrospectiveLigationSymptoms onlyYes466.55Spanos et al. \[[@CR13]\]USAProspectiveLigationUniversal scopingYes4119.56Spanos et al. \[[@CR13]\]USAProspectiveClipUniversal scopingYes2718.56Vanamo et al. \[[@CR34]\]FinlandProspectiveLigationSymptoms onlyNo1106.45Vida et al. \[[@CR35]\]ItalyProspectiveClipSymptoms onlyNo1500.76Villa et al. \[[@CR13]\]FranceRetrospectiveClipSelective scopingNo7212.55Villa et al. \[[@CR13]\]FranceRetrospectiveClipSelective scopingYes2213.65Zbar et al. \[[@CR4]\]USARetrospectiveLigationSelective scopingNo817.46^a^Vocal cord paralysis was diagnosed based on symptoms only^b^Only symptomatic patients had laryngoscopy postoperatively to confirm vocal cord paralysis^c^All patients were scoped with laryngoscopy postoperatively

In total, fourteen studies were prospective and the other nineteen were retrospective. Ligation was the most frequently used surgical closure approach. Only one study analyzed all patients with laryngoscopy preoperatively. A total of seven studies scoped all patients postoperatively with laryngoscopy to assess for VCP. All of those studies used a surgical approach and 6/7 analyzed premature patients. Ten studies utilized selective scoping with laryngoscopy of patients that showed symptoms suggestive of VCP. Sixteen studies identified patients with VCP based only on symptoms or method was not mentioned.

Overall Incidence of VCP {#Sec10}
------------------------

A total of 33 studies (*n* = 4887 subjects) reported extractable data on the incidence of VCP in all age populations after PDA closure (Table [2](#Tab2){ref-type="table"}). Overall pooled incidence estimate of VCP was 7.9% (95%CI 5.3--10.9) (Fig. [2](#Fig2){ref-type="fig"}).

Table 2Overall incidence of vocal cord paralysis after patent ductus arteriosus closureSubgroupNumber of studies (number of subjects)Pooled incidence of VCP after PDA closure: % (95% CI)*I*^2^ (%)Cochran's Q, *p* valueOverall33 (4887)7.9 (5.3--10.9)91.1\< 0.001Method of PDA closure Surgical ligation20 (1805)11.1 (7.2--15.8)86.5\< 0.001 Surgical clipping11 (2926)2.4 (1.3--3.9)69.00.001Method to assess for VCP Universal laryngoscopy scoping^a^7 (291)24.2 (14.5--35.3)75.00.001 Selective laryngoscopy scoping^b^10 (1770)9.1 (4.2--15.6)92.4\< 0.001 Symptoms scoping^c^15 (2715)2.2 (1.3--3.3)50.30.013Geographical origin Asia2 (1358)1.0 (0.5--1.6)0.000.582 Europe11 (1732)4.5 (2.3--7.3)77.7\< 0.001 North America17 (1497)11.5 (7.4--16.5)84.5\< 0.001*PDA* patent ductus arteriosus, *VCP* vocal cord paralysis^a^All patients were scoped with laryngoscopy postoperatively to assess for VCP^b^Only symptomatic patients had laryngoscopy to assess for VCP^c^VCP was diagnosed only based on symptoms

Fig. 2Forest plot for overall pooled incidence rate of vocal cord paralysis

VCP occurred most often in patients treated with surgical ligation (11.1%; \[95%CI 7.2--15.8\]). Surgical clipping caused significantly less VCP than surgical ligation, with pooled VCP incidence rate of 2.4% (95%CI 1.3--3.9). Analysis of studies assessing all patients postoperatively with laryngoscopy (24.2% \[95%CI 14.5--35.3\]) showed significantly higher pooled incidence of VCP than studies that diagnosed VCP based only on symptoms (2.2% \[95%CI 1.3--3.3\], Table [2](#Tab2){ref-type="table"}) or studies assessing only symptomatic patients (9.1% \[95%CI 4.2--15.6\]).

Geographical analysis revealed that VCP after PDA closure occurred more often in North America (11.5% \[95%CI 7.4--16.5\]) than in Europe (4.5% \[95%CI 2.3--7.3\]) or Asia (1.0% \[95%CI 0.5--1.6\]).

Incidence of VCP in Premature/Low Birth Weight Patients {#Sec11}
-------------------------------------------------------

Twenty-two studies (*n* = 1895 patients) were included in the analysis on the incidence of VCP after PDA closure in premature newborns (Table [3](#Tab3){ref-type="table"}). The overall pooled incidence of VCP in this population was 11.2% (95%CI 7.0--16.3). Premature infants were more likely to develop VCP after surgical ligation (11.7%; \[95%CI 6.9--17.5\]) than surgical clipping (6.8%; \[95%CI 0.7--16.9\]). Subgroup analysis on geographical origin showed that VCP in premature patients seems to occur more frequently in North America (14.0%; \[95%CI 8.6--20.5\]) than Europe (8.2%; \[95%CI 2.5--16.4\]).

Table 3Incidence of vocal cord paralysis after patent ductus arteriosus closure in premature /low birth weight patientsSubgroupNumber of studies (number of subjects)Pooled incidence of VCP after PDA closure: % (95% CI)*I*^2^ (%)Cochran's Q, *p* valueOverall22 (1895)11.2 (7.0--16.3)89.2\< 0.001Method of PDA closure Surgical ligation16 (1552)11.7 (6.9--17.5)89.0\< 0.001 Surgical clipping4 (187)6.8 (0.7--16.9)73.50.010Geographical origin Europe7 (419)8.2 (2.5--16.4)81.3\< 0.001 North America12 (1176)14.0 (8.6--20.5)85.3\< 0.001*PDA* patent ductus arteriosus, *VCP* vocal cord paralysis

Incidence of VCP in Non-premature Patients {#Sec12}
------------------------------------------

Ten studies (*n* = 2874 patients) reported extractable data on the incidence of VCP after PDA closure in non-premature patients (Table [4](#Tab4){ref-type="table"}). The overall pooled incidence estimate in this population was 3.0% (95%CI 1.5--4.9). Again, surgical ligation resulted in significantly higher incidence of VCP (8.6%; \[95%CI 5.0--13.0\]) than surgical clipping (1.5%; \[95%CI 0.9--2.3\]). Subgroup analysis on geographical origin showed that VCP in non-premature patients seems to occur more frequently in North America (7.1% \[95%CI 2.2--14.4\]) than other regions.

Table 4Vocal cord paralysis after patent ductus arteriosus closure in non-premature patientsSubgroupNumber of studies (number of subjects)Pooled incidence of VCP after PDA closure: % (95% CI)*I*^2^ (%)Cochran's Q, *p* valueOverall10 (2874)3.0 (1.5--4.9)77.7\< 0.001Method of PDA closure Surgical clipping6 (2621)1.5 (0.9--2.3)59.40.043 Surgical ligation4 (253)8.6 (5.0--13.0)18.30.299Geographical origin Asia2 (1358)1.0 (0.5--1.6)0.000.582 Europe4 (1313)2.4 (1.1--4.1)60.00.059 North America4 (203)7.1 (2.2--14.4)60.70.054*PDA* patent ductus arteriosus, *VCP* vocal cord paralysis

Duration of Vocal Cord Paralysis {#Sec13}
--------------------------------

Overall, 10 studies (*n* = 121 patients with VCP) analyzed the duration of VCP after PDA closure. A total of 72.3% (95%CI 30.8--100.0; *I*^2^ = 92.0; *p* \< 0.001) of patients developed transient VCP. In premature newborns (five studies, 82 patients with VCP), the majority (64.9%; 95%CI 20.2--100.0%; *I*^2^ = 84.5; *p* \< 0.001) suffered from persistent VCP. Lastly, an analysis of six studies (*n* = 46 patients with VCP) on non-premature patients showed that these patients more often had transient VCP (83.4%; 95%CI 71.5--92.8%; *I*^2^ = 0.0; *p* = 0.631).

Risk Factors of VCP {#Sec14}
-------------------

### Birth Weight {#Sec15}

Six studies (*n* = 321 subjects) compared the birth weight between preterm infants with VCP and those without VCP (Table [5](#Tab5){ref-type="table"}). It should be noted that birth weight in preterm infants with VCP was significantly lower than those without VCP (WMD = − 149.03 g; 95%CI − 269.02 to − 29.05 g; *p* = 0.02).

Table 5Risk factors and comorbidities in premature infants/low birth weight infants for vocal cord paralysis after patent ductus arteriosus closureRisk factor/comorbidityNumber of studies included (number of patients)Type of outcome calculationValue of outcome analysis (95% CI)*p* value*I*^2^ (%)Cochran's Q, *p* valueBirth weight6 (321)WMD− 149.03 g (− 269.02 to − 29.05)0.0290.3\< 0.001Gestational age6 (321)WMD− 1.21 week (− 1.79 to − 0.63)\< 0.0164.10.016Weight at ligation4 (287)WMD− 258.00 g (− 548.15 to 32.15)0.0896.8\< 0.001Days of life at ligation4 (224)WMD− 8.96 days (− 26.17 to 8.25)0.3198.0\< 0.001Bronchopulmonary dysplasia4 (200)RR1.23 (1.00− 1.51)0.0490.00.974Duration of mechanical ventilation3 (89)WMD16.16 days (4.24 to 28.08)\< 0.0158.60.089Gastrostomy tube insertion3 (224)RR1.22 (1.00 to 1.49)0.0357.80.069*CI* confidence interval, *RR* relative risk, *WMD* weighted mean difference

### Gestational Age {#Sec16}

Six studies (*n* = 321 subjects) reported the gestational age of preterm infants with and without VCP. As shown in Table [5](#Tab5){ref-type="table"}, gestational age in preterm infants with VCP was significantly lower than those without VCP (WMD = − 1.21 weeks; 95%CI − 1.79 to − 0.63 weeks; *P* \< 0.01).

### Weight at Ligation {#Sec17}

Four studies (*n* = 287 subjects) compared the weight at ligation between preterm infants with and without VCP. Pooled results in Table [5](#Tab5){ref-type="table"} indicate that weight at ligation in preterm infants with VCP was lower than those without VCP (WMD = − 258.00 g; 95%CI − 548.15 to − 32.15 g; *p* = 0.08); however, the difference was not significant.

### Days of Life at Ligation {#Sec18}

Four studies (*n* = 224 subjects) compared the days of life at ligation between preterm infants with and without VCP. Table [5](#Tab5){ref-type="table"} shows that the total days of life at ligation in preterm infants with VCP was shorter than those without VCP (WMD = − 8.96 days; 95%CI − 26.17 to 8.25 days; *p* = 0.31); however, the difference was not significant.

Comorbidities of VCP {#Sec19}
--------------------

### Bronchopulmonary Dysplasia {#Sec20}

There was slight significant difference in the incidence of BPD in preterm infants with and without VCP, indicating that preterm infants with VCP were mildly more likely to suffer from BPD (four studies, *n* = 200 subjects; RR = 1.23; 95%CI 1.00--1.51; *p* = 0.049; I^2^ = 0.0, Table [5](#Tab5){ref-type="table"}).

### Duration of Mechanical Ventilation {#Sec21}

The effect estimate revealed a significant difference in total days of mechanical ventilation between preterm infants with and without VCP (Table [5](#Tab5){ref-type="table"}), showing that preterm infants with VCP needed prolonged mechanical ventilation (three studies, *n* = 89 patients; WMD = 16.16 days; 95%CI 4.24--28.08 days; *p* \< 0.01).

### Gastrostomy Tube Insertion {#Sec22}

Meta-analysis of three studies (*n* = 224 subjects) showed that there was slight significant difference in the incidence of gastrostomy tube insertion between preterm infants with and without VCP, indicating that preterm infants with VCP were more likely to require gastrostomy tube insertion (RR = 1.22; 95%CI 1.00--1.49; *p* = 0.03; Table [5](#Tab5){ref-type="table"}).

Discussion {#Sec23}
==========

The ductus arteriosus is indispensable in the maintenance of fetal circulation. Failure to close in the first few days after birth may result in high morbidity and mortality if not treated correctly. Surgery is the standard method of closure in approximately a quarter of extremely low birth weight infants, as reported by the National Institute of Child Health and Human Development Neonatal Research Network \[[@CR37]\]. Though the advantages of surgical closure of PDA and its short- and long-term efficacy and safety have been highlighted, multiple studies have demonstrated that VCP remains a common complication of these procedures. This meta-analysis assessed the incidence of VCP in various age populations and evaluated its risk factors and comorbidities in preterm infants following interventional closure of PDA.

To date, the true incidence of VCP after interventional PDA closure has been unclear. Our meta-analysis involving 4887 patients from 33 studies showed that the total incidence of VCP was (7.9% \[95%CI 5.3--10.9\]). The incidence of VCP after PDA closure was significantly higher in premature infants (11.2% \[95%CI 7.0--16.3\]) than in non-premature patients (3.0% \[95%CI 1.5--4.9\]), indicating premature infants are at a greater risk of VCP. Truong et al.'s study \[[@CR6]\] illustrated that compared with term infants, preterm infants are less likely to recover vocal cord function. It could also be demonstrated in our study as persistent VCP occurred more frequently in premature newborns, while transient VCP was more commonly found in non-premature patients. A lower incidence of VCP after surgical clipping was found in this study, along with shorter operative time and lower risk of bleeding \[[@CR25]\], should effectively encourage the use of this technique of surgical PDA closure in appropriately qualified patients.

The method of assessing and diagnosing VCP is of crucial importance in discerning the true incidence of this complication. The analysis of studies that scoped all patients postoperatively with laryngoscopy, regardless of the presence of laryngeal symptoms, showed significantly higher incidence of VCP (24.2%) as compared to studies that assessed only symptomatic patients (7.5%) or based diagnosis of VCP on symptoms alone (2.0%). Though the majority of universal scoping studies were done on premature patients, which had a higher incidence of VCP to begin with, these findings suggest that VCP might be highly underestimated. This is particularly evident by the low pooled incidence of VCP in studies diagnosing patients only based on symptoms. Geographical differences may be partially attributed to the lack of studies conducting universal laryngoscopy scoping in Europe and Asia, thus underestimating the incidence of VCP in those continents.

Birth weight and gestational age were significantly associated with the occurrence of VCP. Even though the difference was not significant, the weight at ligation and days of life at ligation in preterm infants with VCP were lower than those without VCP. It is not unexpected, as the smaller and weaker infants are more likely to suffer from complication PDA surgical closure.

Preterm infants with VCP were more likely to have respiratory problems. The exact causal relationship between VCP and BPD remains unclear. Chronic microaspiration due to impaired airway protection following extubation could be a mechanism causing ongoing lung injury; however, it also is possible that infants with the most-severe lung disease are most likely to undergo surgical treatment of PDA \[[@CR17]\]. Along with the development of BPD, the functional residual capacity has been shown to be reduced, which requires glottal closure to create positive-end expiratory pressure. Extubated infants with VCP and secondary glottic incompetence may experience decreased pulmonary function, leading to prolonged mechanical support to maintain functional residual capacity. Moreover, the high risk of aspiration for infants with VCP may induce lung injury and contribute to a prolonged duration of mechanical ventilation.

Swallowing difficulties are common manifestation of vocal cord dysfunction after cardiothoracic surgery, leading to significant feeding problems \[[@CR38]\]. Compared with infants who did not have symptoms of VCP following PDA surgery, those with VCP were more likely to have ongoing problems with feeding and growth, thereby requiring total or supplemental tube feedings at hospital discharge.

Several limitations of this meta-analysis should be considered. First, despite the high incidence of VCP in the preterm infants following PDA surgery, there remains a lack of coordinated, high-quality studies in the literature. In addition, many included studies are limited by their retrospective design. The incidence of VCP may be highly underestimated because most asymptomatic patients did not undergo laryngoscopy and a large proportion of patients were diagnosed based on symptoms alone.

Conclusions {#Sec24}
===========

We report an overall VCP pooled incidence of 6.9% and high pooled incidence of VCP in premature infants (11.7%). The data showed that VCP was most common after surgical ligation and was the highest in studies conducting universal laryngoscopy scoping. The risk factors for postoperative VCP in preterm infants included birth weight and gestational age. In addition, VCP was associated with the occurrence of BPD and gastrostomy tube insertion, as well as an increased duration of mechanical ventilation.
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